Jennifer Clare Jones | |
---|---|
![]() | |
Other names | Jennifer Jones McIntire |
Alma mater | Stanford University |
Scientific career | |
Fields | Radiation oncology, translational nanobiology |
Institutions | National Cancer Institute |
Thesis | Identification of Tapr, a T cell and airway phenotype regulatory locus, and positional cloning of the Tim gene family (2001) |
Doctoral advisor | Dale Umetsu |
Jennifer Clare Jones is an American radiation oncologist and biologist. She is an investigator and head of the translational nanobiology section at the National Cancer Institute.
Jones completed a M.D. and Ph.D. from Stanford University. She is a board-certified radiation oncologist specialized training in radiosurgery, with graduate and postdoctoral training in both cancer biology and general immunology. [1] Her doctoral advisor was Dale Umetsu . Jones' dissertation in 2001 was titled, Identification of Tapr, a T cell and airway phenotype regulatory locus, and positional cloning of the Tim gene family. [2]
Jones is a NIH Stadtman Investigator and head of the translational nanobiology section at the National Cancer Institute. [3]
From 2001 to 2003, Jones positionally cloned the T-cell immunoglobulin mucin (TIM) gene family and demonstrated the genetic association between TIMs and immune response profiles. As a radiation oncologist, her research is focused on developing immune-based therapies that synergize with radiation to produce optimal anti-tumor immune responses. Jones develops improved methods to characterize, sort, and perform functional studies of nanoparticles, and has established a translational EV analysis pipeline, with instrumentation for preparation, analysis, counting, and cytometric study of extracellular vesicles. [3]
A genetic screen or mutagenesis screen is an experimental technique used to identify and select individuals who possess a phenotype of interest in a mutagenized population. Hence a genetic screen is a type of phenotypic screen. Genetic screens can provide important information on gene function as well as the molecular events that underlie a biological process or pathway. While genome projects have identified an extensive inventory of genes in many different organisms, genetic screens can provide valuable insight as to how those genes function.
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is one of the institutes and centers that make up the National Institutes of Health, an agency of the United States Department of Health and Human Services (HHS).
Genetics, a discipline of biology, is the science of heredity and variation in living organisms.
The Wistar Institute is an independent, nonprofit research institution in biomedical science with special focuses in oncology, immunology, infectious disease and vaccine research. Located on Spruce Street in Philadelphia’s University City neighborhood, Wistar was founded in 1892 as a nonprofit institution to focus on biomedical research and training.
Upstream stimulatory factor 1 is a protein that in humans is encoded by the USF1 gene.
OX-2 membrane glycoprotein, also named CD200 is a human protein encoded by the CD200 gene. CD200 gene is in human located on chromosome 3 in proximity to genes encoding other B7 proteins CD80/CD86. In mice CD200 gene is on chromosome 16.
Zinc finger protein Helios is a protein that in humans is encoded by the IKZF2 gene. This protein is a member of Ikaros family of transcription factors.
Harald von Boehmer was a German-Swiss immunologist best known for his work on T cells.
The Interleukin-2 receptor alpha chain is a protein involved in the assembly of the high-affinity Interleukin-2 receptor, consisting of alpha (IL2RA), beta (IL2RB) and the common gamma chain (IL2RG). As the name indicates, this receptor interacts with Interleukin-2, a pleiotropic cytokine which plays an important role in immune homeostasis.
Francis Sellers Collins is an American physician-scientist who discovered the genes associated with a number of diseases and led the Human Genome Project. He served as director of the National Institutes of Health (NIH) in Bethesda, Maryland, from 17 August 2009 to 19 December 2021, serving under three presidents.
Nicholas P. Restifo is an American immunologist, physician and educator in cancer immunotherapy. Until July 2019, he was a tenured senior investigator in the intramural National Cancer Institute of the National Institutes of Health at Bethesda, Maryland. Nicholas was an executive vice president of research at Lyell based in San Francisco.
Interleukin 1 receptor-like 1, also known as IL1RL1 and ST2, is a protein that in humans is encoded by the IL1RL1 gene.
BPI fold-containing family B member 1 (BPIFB1) is a protein that in humans is encoded by the BPIFB1 gene. BPIFB1 is a secreted protein, expressed at very high levels in mucosa of the airways and salivary glands, and at moderate levels in the digestive tract and pancreas.
Branimir Ivan "Brandy" Sikic is an American medical doctor and scientist at Stanford University School of Medicine. He is an oncologist and cancer pharmacologist, and has served as a faculty member at Stanford University since 1979. His research spans basic, translational, and clinical research and investigates the mechanisms of drug resistance and the development of new anticancer therapies.
David R. Gius is an American physician-scientist the Zell Family Scholar Professor, Women's Cancer Research Program director, and Vice Chair of Translational Research at Northwestern University's Feinberg School of Medicine Department of Radiation Oncology and Pharmacology. His research focuses into the mechanistic connection between aging, cellular and/or mitochondrial metabolism, and carcinogenesis focusing on the Sirtuin gene family.
Hatice Efsun Arda is a Turkish developmental and systems biologist researching cell lineages that give rise to human pancreas using single cell sequencing. She is a Stadtman principal investigator and head of the developmental genomics group at the National Cancer Institute.
Rosandra N. Kaplan is an American pediatric oncologist and scientist specialized in translational and clinical research on the mechanisms of cancer spread and the role of the tumor microenvironment in cancer progression. She is a principal investigator and head of the tumor microenvironment and metastasis branch at the National Cancer Institute.
Jung-Min Lee is a South Korean-American medical oncologist and physician-scientist focused on the early clinical drug development and translational studies of targeted agents in BRCA mutation-associated breast or ovarian cancer, high-grade epithelial ovarian cancer, and triple-negative breast cancer. She is a NIH Lasker Clinical Research Scholar and principal investigator in the Women's Malignancies Branch at the National Cancer Institute.
Ludmila Prokunina-Olsson is a molecular medical geneticist who conducts genetic and functional analyses downstream of genome-wide association studies (GWAS) for various human traits, including cancer, immune and infectious diseases. She is chief of the Laboratory of Translational Genomics (LTG) at the National Cancer Institute.
Yi Sun (孙毅) is a Chinese–American distinguished molecular biologist and oncologist, specialized in protein ubiquitylation and neddylation. He served as professor emeritus of Radiation Oncology at University of Michigan. He is the Qiushi Chair Professor at the 2nd Affiliated Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, China.